National Congress Italian Society of Invasive Cardiology (GISE)

November 16, 2016 — A poster presentation at the American Heart Association Scientific Sessions shows that voice analysis can be used to identify the presence of coronary artery disease (CAD). The study indicates a strong correlation between certain voice characteristics and CAD, which represents a significant breakthrough in this field. This finding can significantly improve continuous monitoring and reduce remote healthcare costs related to CAD.

November 21, 2016 – Healthcare providers seeking versatile imaging technology for their angiography needs can find a customized solution with Toshiba Medical’s Infinix-i product line. From embolization, angioplasty, shunt repair or virtually any other image-guided procedure, including those in hybrid OR settings, the Infinix-i delivers optimum image quality, industry leading dose management tools and unprecedented flexibility and patient access.

November 21, 2016 – A single-center study sponsored by the National Institutes of Health (NHLBI) failed to show an early benefit of postconditioning (the application of brief periods of ischemia during the initial phase of reperfusion) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention (PCI) and stenting.

ScImage Inc. announced it has secured orders for cardiovascular imaging systems (CVIS) at six Department of Defense (DoD) medical centers. The sales are part of its DIN-PACS III (Digital Imaging Network/Picture Archiving and Communications System) contract.

November 21, 2016 — Arterys will showcase its recently U.S. Food and Drug Administration (FDA) 510(k)-cleared Arterys Software platform at the upcoming Radiological Society of North America (RSNA) 2016 meeting, Nov. 27-Dec. 1 in Chicago. The company will also present new data on cardiac clinical applications using the Arterys 4-D Flow software during the RSNA poster sessions.

November 21, 2016 — Philips introduced DoseWise Portal 2.2, a next-generation radiation dose management software platform for healthcare providers to record, track and analyze radiation exposure to patients and clinicians.

November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a new independent study that evaluated the company’s CGuard embolic protection system (EPS) in patients with symptomatic or high-grade asymptomatic internal carotid artery (ICA) stenosis.

Mitralign Inc. announced the successful compassionate use treatment of a patient suffering from tricuspid regurgitation (TR) with their investigational Trialign System. The patient was suffering from TR due to a cardiac implantable electronic device lead.

Boston Scientific recently announced results from the first clinical trial evaluating the performance of the HeartLogic Heart Failure Diagnostic Service to predict impending heart failure (HF) decompensation. Data collected from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study were presented as a late-breaking clinical trial at the American Heart Association (AHA) Scientific Sessions 2016, Nov. 12-16 in New Orleans, and confirmed the HeartLogic alert provided a highly sensitive and timely predictor of a future HF event.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now